Caryl and Israel Englander
Institute for Precision Medicine

You are here

Patient Information

A diagnosis of cancer can be devastating, and traditional cancer treatments, which often cause unpleasant to debilitating side effects, can be challenging, too. At The Caryl and Israel Englander Institute for Precision Medicine our goal is to identify a targeted therapeutic approach for each patient we see. Because these treatment recommendations are based on targeted therapies they might not fit the standard, established protocol for a tumor.

Currently we see patients with advanced or refractory cancer who are referred by their physicians to our Precision Medicine Clinic, which is led by medical oncologist Himisha Beltran, MD. We enroll patients at the Institute through an Institutional Review Board-approved clinical trial, then obtain samples of both their normal and tumor tissue, and analyze these samples using genomic sequencing techniques. This sequencing strategy enables us to identify specific targets for treatment.

The results of our genomic analysis and patients’ medical history are reviewed by a multi-institutional Precision Medicine Tumor Board, which includes experts in medical oncology, pathology, computational biology, genetics, and ethics. The Tumor Board will collaboratively develop a treatment plan tailored to each patient, and IPM will then share this plan with patients’ clinicians, who then discuss the results with the patient. 

Physicians at the Precision Medicine Clinic follow patients to see how they are responding to therapy. This information is captured in a clinical database, and will help the IPM team discover and develop therapeutic approaches to benefit many more patients with cancer and other diseases.

Patients are seen in the Precision Medicine Clinic on a referral only basis. If you are a patient who is interested in precision medicine, please speak to your doctor or make an appointment with one of our referring clinicians.

Referring Physician Specialty
Christopher Barbieri, M.D., Ph.D. Prostate Cancer
Urologic Cancer
David Nanus, M.D. Intestinal Cancer
Prostate Cancer
Bladder Cancer
Kidney Cancer
Divya Gupta, M.D. Gynecologic Cancers  
Douglas Scherr, M.D. Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Urologic Cancer
Ellen Ritchie, M.D. Leukemia
Ellen Scherl, M.D. Gastroenterology
Fabrizio Michelassi, M.D. Surgical Oncology
Himisha Beltran, M.D. Testicular Cancer
Kidney Cancer
Bladder Cancer
Prostate Cancer
Urologic Cancer
Jeffrey Greenfield, M.D. Pediatric Head and Neck Cancer
Pediatric Brain Cancer
Jeffrey Milsom, M.D. Colon Cancer
Colorectal Cancer
Anal Cancer
Rectal Cancer
Kevin Holcomb, M.D. Uterine Cancer
Ovarian Cancer
Cervical Cancer
Vulvar Cancer
Koen van Besien, M.D., Ph.D. Leukemia
Lymphoma
Manish Shah, M.D. Esophageal Cancer
Gastric Cancer
Colorectal Cancer
Pancreas Cancer
Liver Cancer
Peter Martin, M.D. Lymphoma
Leukemia
Richard Furman, M.D. Leukemia
Lymphoma
Ronald Scheff, M.D. Thoracic Cancer
Brain Cancer
Lung Cancer
Scott Tagawa, M.D. Prostate Cancer
Bladder Cancer
Testicular Cancer
Kidney Cancer
Urologic Cancer
Steven Lipkin, M.D., Ph.D. Cancer Genetics
Theodore Schwartz, M.D. Brain Cancer
Yariv Houvras, M.D. Gastrointestinal Cancer

Weill Cornell Medicine
Caryl and Israel Englander
Institute for Precision Medicine
413 E 69th Street
Belfer Research Building
New York, NY 10021 Phone: